Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. 1995

W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
Mental Retardation Research Center, University of California, Los Angeles 90024-1759, USA.

In view of studies showing that not only nitric oxide synthase (NOS) activity but arginase activity is induced in rodent macrophages by lipopolysaccharide (LPS), the objective of this study was to investigate the co-induction of these two enzymes and to ascertain whether common mechanisms are involved. RAW 264.7 cells were activated by 2 micrograms LPS/ml and incubated for up to 48 hr. Inducible NOS (iNOS) and inducible arginase II (AII) activities were monitored, respectively, by measuring NO2-/NO3- accumulation in cell culture media and formation of urea (as CO2) from L-arginine by cell lysates. AII activity increased linearly up to at least 48 hr, whereas NO2-/NO3- formation reached a plateau well before 48 hr. Immunoprecipitation experiments revealed that AII accounted for 90-100% of arginase activity in LPS-activated macrophages. The inhibitor of NF-kappa B activation, pyrrolidine dithiocarbamate, inhibited the induction of iNOS but not AII. Moreover, whereas IFN-gamma caused iNOS induction, AII induction was nearly abolished by IFN-gamma, perhaps by inhibiting transcription of the AII gene. These observations indicate that co-induction of iNOS and AII occurs by distinct transcriptional mechanisms, AII induction could diminish NO production by decreasing L-arginine availability, and IFN-gamma can prevent AII induction.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D009573 Nitrites Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M Nitrite
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004790 Enzyme Induction An increase in the rate of synthesis of an enzyme due to the presence of an inducer which acts to derepress the gene responsible for enzyme synthesis. Induction, Enzyme
D000594 Amino Acid Oxidoreductases A class of enzymes that catalyze oxidation-reduction reactions of amino acids. Acid Oxidoreductases, Amino,Oxidoreductases, Amino Acid
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
July 1993, Immunology,
W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
September 1993, Journal of immunology (Baltimore, Md. : 1950),
W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
January 1994, The Biochemical journal,
W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
January 1998, The American journal of physiology,
W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
July 2003, Archives of toxicology,
W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
June 1993, European journal of immunology,
W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
May 2000, Infection and immunity,
W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
July 1993, European journal of immunology,
W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
March 2006, Immunology,
W W Wang, and C P Jenkinson, and J M Griscavage, and R M Kern, and N S Arabolos, and R E Byrns, and S D Cederbaum, and L J Ignarro
August 1994, Biochemical and biophysical research communications,
Copied contents to your clipboard!